- Home
- FNLC vs OSUR Comparison
FNLC vs OSUR Comparison
Compare FNLC & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNLC | OSUR |
|---|---|---|
| Founded | 1864 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.3M | 275.4M |
| IPO Year | 1995 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FNLC | OSUR |
|---|---|---|
| Price | $29.47 | $4.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 9.9K | ★ 871.9K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.19% | N/A |
| EPS Growth | ★ 26.34 | N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | $36.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.44 | $2.08 |
| 52 Week High | $30.33 | $4.33 |
Technical Indicators
Market Signals| Indicator | FNLC | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 61.20 | 65.45 |
| Support Level | $28.08 | $2.93 |
| Resistance Level | $29.99 | $4.33 |
| Average True Range (ATR) | 0.66 | 0.23 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 99.90 | 79.27 |
Price Performance
Historical ComparisonAbout FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.